Atlas Trials

Study of BIIB092 in Participants With Progressive Supranuclear Palsy

Clinical trial NCT03068468 · TERMINATED

Trial details

NCT number
NCT03068468
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Supranuclear Palsy, Progressive
Start date
2017-06-01
Primary completion
2019-09-06
Enrollment
490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.